Hyundai Rotem Co (064350)
Korea Stock Exchange · Korea · prices in KRW · close of 20 Oct 2026
Key indicators
| Last close | KRW 86,900.00 |
|---|---|
| 52-week range | 86,300.00 – 282,000.00 |
| Return, 1 month / 3 months | −28.4% / −48.2% |
| Return, 1 year / 3 years | −60.8% / +184.7% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 71.7% |
| Worst drawdown (1 year) | -67.7% |
| Average daily value traded | 54,304.12M KRW |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hyundai Rotem is a South Korean manufacturer of railway vehicles and defence equipment. It builds high-speed trains, subway cars, locomotives and freight wagons for rail operators, and it produces tanks and other armoured vehicles for military customers. The company also supplies related systems and maintenance services for rail fleets. Its customers are mainly public transport authorities, national rail operators and defence organisations, and its manufacturing and engineering work is based in Korea.
Hyundai Rotem Co trades under the code 064350 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hyundai Rotem Co (064350) trades on the Korea Stock Exchange in Korea. It last closed at KRW 86,900.00 on 20 October 2026.
Its price-based Market X-Ray is 21 out of 100 (a weak price profile), ranking 882 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 60.8% and over the last three months it fell 48.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 4 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -52.0% | ||
| From 52-week high | -67.7% | ||
| Momentum | 4 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -48.2% | ||
| 6-month return | -58.0% | ||
| 12-month return, skipping the last month | -45.3% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 71.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 54,304.12M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 9 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −11.1% |
|---|---|
| 1 month | −28.4% |
| 3 months | −48.2% |
| 6 months | −58.0% |
| 1 year | −60.8% |
| 3 years | +184.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 123,952.00 / 181,149.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6,486.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 600.0000 |
| 28 Mar 2025 | KRW 200.0000 |
| 27 Dec 2023 | KRW 100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.